309 related articles for article (PubMed ID: 36111346)
1. The pathophysiological mechanisms underlying diabetic retinopathy.
Wei L; Sun X; Fan C; Li R; Zhou S; Yu H
Front Cell Dev Biol; 2022; 10():963615. PubMed ID: 36111346
[TBL] [Abstract][Full Text] [Related]
2. Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.
Moran EP; Wang Z; Chen J; Sapieha P; Smith LE; Ma JX
Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H738-49. PubMed ID: 27473938
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.
Cai Y; Kang Y
Biomed Pharmacother; 2023 Aug; 164():114994. PubMed ID: 37301133
[TBL] [Abstract][Full Text] [Related]
4. The gut-retina axis: a new perspective in the prevention and treatment of diabetic retinopathy.
Zhang H; Mo Y
Front Endocrinol (Lausanne); 2023; 14():1205846. PubMed ID: 37469982
[TBL] [Abstract][Full Text] [Related]
5. Neurovascular unit in diabetic retinopathy: pathophysiological roles and potential therapeutical targets.
Nian S; Lo ACY; Mi Y; Ren K; Yang D
Eye Vis (Lond); 2021 May; 8(1):15. PubMed ID: 33931128
[TBL] [Abstract][Full Text] [Related]
6. Recent Insights into the Role of Gut Microbiota in Diabetic Retinopathy.
Jiao J; Yu H; Yao L; Li L; Yang X; Liu L
J Inflamm Res; 2021; 14():6929-6938. PubMed ID: 34938095
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration in the pathogenesis of diabetic retinopathy: molecular mechanisms and therapeutic implications.
Stem MS; Gardner TW
Curr Med Chem; 2013; 20(26):3241-50. PubMed ID: 23745549
[TBL] [Abstract][Full Text] [Related]
8. Research progress of diabetic retinopathy and gut microecology.
Wang R; Wang QY; Bai Y; Bi YG; Cai SJ
Front Microbiol; 2023; 14():1256878. PubMed ID: 37744925
[TBL] [Abstract][Full Text] [Related]
9. Diabetic Retinopathy - Pathophysiology to Treatment: A Review.
Dahiya R; Walia A; Kaur J; Kumar P; Verma I; Rani N
Curr Diabetes Rev; 2024 Jan; ():. PubMed ID: 38315658
[TBL] [Abstract][Full Text] [Related]
10. Combinational Approaches Targeting Neurodegeneration, Oxidative Stress, and Inflammation in the Treatment of Diabetic Retinopathy.
Chalke SD; Kale PP
Curr Drug Targets; 2021; 22(16):1810-1824. PubMed ID: 33745432
[TBL] [Abstract][Full Text] [Related]
11. Frontiers in Understanding the Pathological Mechanism of Diabetic Retinopathy.
Zhan L
Med Sci Monit; 2023 Jun; 29():e939658. PubMed ID: 37307243
[TBL] [Abstract][Full Text] [Related]
12. Advances in Research Related to MicroRNA for Diabetic Retinopathy.
Luo Y; Li C
J Diabetes Res; 2024; 2024():8520489. PubMed ID: 38375094
[TBL] [Abstract][Full Text] [Related]
13. Aging and diabetic retinopathy: Inherently intertwined pathophysiological processes.
Li Q; Wang M; Li X; Shao Y
Exp Gerontol; 2023 May; 175():112138. PubMed ID: 36893949
[TBL] [Abstract][Full Text] [Related]
14. Role of toll-like receptor 4 in diabetic retinopathy.
Bayan N; Yazdanpanah N; Rezaei N
Pharmacol Res; 2022 Jan; 175():105960. PubMed ID: 34718133
[TBL] [Abstract][Full Text] [Related]
15. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
Mudaliar S; Hupfeld C; Chao DL
J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
[TBL] [Abstract][Full Text] [Related]
16. Neurovascular Cell Death and Therapeutic Strategies for Diabetic Retinopathy.
Oshitari T
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629100
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota: A potential therapeutic target for management of diabetic retinopathy?
Alarcón Yempén RE; Venzel R; Paulino Campos MC; de Oliveira LP; Lins RVD; Pessoni AM; Fanaro GB; de Oliveira Souza A; Calaza KDC; de Brito Alves JL; Cavalcanti-Neto MP
Life Sci; 2021 Dec; 286():120060. PubMed ID: 34666038
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications-risks and mitigation.
Kropp M; Golubnitschaja O; Mazurakova A; Koklesova L; Sargheini N; Vo TKS; de Clerck E; Polivka J; Potuznik P; Polivka J; Stetkarova I; Kubatka P; Thumann G
EPMA J; 2023 Mar; 14(1):21-42. PubMed ID: 36866156
[TBL] [Abstract][Full Text] [Related]
19. Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration.
Aldosari DI; Malik A; Alhomida AS; Ola MS
Front Neurosci; 2022; 16():938029. PubMed ID: 35911994
[TBL] [Abstract][Full Text] [Related]
20. Diabetic Retinopathy: Pathophysiology and Treatments.
Wang W; Lo ACY
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
